HSDT Key Statistics, Chart & Performance
The current stock price of HSDT is 4.14 USD. In the past month the price decreased by -37.04%. In the past year, price decreased by -99.17%.
HSDT Latest News, Press Relases and Analysis
HSDT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.41 | 220.49B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.71 | 200.56B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.08 | 149.06B | ||
| SYK | STRYKER CORP | 28.09 | 141.49B | ||
| IDXX | IDEXX LABORATORIES INC | 58.32 | 58.72B | ||
| BDX | BECTON DICKINSON AND CO | 13.2 | 54.57B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.7 | 48.76B | ||
| RMD | RESMED INC | 25.42 | 36.73B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.49 | 36.56B | ||
| DXCM | DEXCOM INC | 34.86 | 25.29B | ||
| PODD | INSULET CORP | 68.03 | 21.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.69 | 18.75B |
Related stock screener links
About HSDT
Company Profile
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Company Info
SOLANA CO
642 Newtown Yardley Road
Newtown PENNSYLVANIA 18940 US
CEO: Dane C. Andreeff
Employees: 21
Phone: 12159446100
SOLANA CO / HSDT FAQ
What does HSDT do?
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Can you provide the latest stock price for SOLANA CO?
The current stock price of HSDT is 4.14 USD. The price increased by 10.7% in the last trading session.
Does SOLANA CO pay dividends?
HSDT does not pay a dividend.
What is the ChartMill technical and fundamental rating of HSDT stock?
HSDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for HSDT stock?
SOLANA CO (HSDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1206.39).
Can you provide the growth outlook for SOLANA CO?
The Revenue of SOLANA CO (HSDT) is expected to decline by -20.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for HSDT stock?
SOLANA CO (HSDT) will report earnings on 2026-03-23, after the market close.
HSDT Technical Analysis
HSDT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HSDT. HSDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
HSDT Financial Highlights
Over the last trailing twelve months HSDT reported a non-GAAP Earnings per Share(EPS) of -1206.39. The EPS increased by 6.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.82% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HSDT Forecast & Estimates
For the next year, analysts expect an EPS growth of 87.29% and a revenue growth -20.09% for HSDT